Inter- and Intrarater Agreement of CT Brain Calcification Scoring in Primary Familial Brain Calcification

References

1. 1.↵
   1. Saleem S,
   2. Aslam HM,
   3. Anwar M, et al

   . Fahr's syndrome: literature review of current evidence. Orphanet J Rare Dis 2013;8:156 doi:10.1186/1750-1172-8-156 pmid:24098952

   CrossRefPubMed
2. 2.↵
   1. Goluke NMS,
   2. Meijer E,
   3. van Maren EA, et al

   . Amount and distribution of intracranial calcification in symptomatic and asymptomatic primary familial brain calcification. Neurol Clin Pract 2023;13:e200163 doi:10.1212/CPJ.0000000000200163 pmid:37179845

   Abstract/FREE Full Text
3. 3.↵
   1. Guo XX,
   2. Zou XH,
   3. Wang C, et al

   . Spectrum of SLC20A2, PDGFRB, PDGFB, and XPR1 mutations in a large cohort of patients with primary familial brain calcification. Hum Mutat 2019;40:392–403 doi:10.1002/humu.23703 pmid:30609140

   CrossRefPubMed
4. 4.↵
   1. Nicolas G,
   2. Charbonnier C,
   3. de Lemos RR, et al

   ; French IBGC Study Group. Brain calcification process and phenotypes according to age and sex: lessons from SLC20A2, PDGFB, and PDGFRB mutation carriers. Am J Med Genet B Neuropsychiatr Genet 2015;168:586–94 doi:10.1002/ajmg.b.32336 pmid:26129893

   CrossRefPubMed
5. 5.↵
   1. Nicolas G,
   2. Pottier C,
   3. Charbonnier C, et al

   ; French IBGC Study Group. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain 2013;136:3395–407 doi:10.1093/brain/awt255 pmid:24065723

   CrossRefPubMed
6. 6.↵
   1. ten Cate O,
   2. Scheele F

   . Competency-based postgraduate training: can we bridge the gap between theory and clinical practice? Acad Med 2007;82:542–47 doi:10.1097/ACM.0b013e31805559c7 pmid:17525536

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Kockelkoren R,
   2. De Vis JB,
   3. Mali WP, et al

   . Hippocampal calcification on computed tomography in relation to cognitive decline in memory clinic patients: a case-control study. PLoS One 2016;11:e0167444 doi:10.1371/journal.pone.0167444

   CrossRefPubMed
8. 8.↵
   1. Gisev N,
   2. Bell JS,
   3. Chen TF

   . Interrater agreement and interrater reliability: key concepts, approaches, and applications. Res Social Adm Pharm 2013;9:330–38 doi:10.1016/j.sapharm.2012.04.004 pmid:22695215

   CrossRefPubMed
9. 9.↵
   1. Koo TK,
   2. Li MY

   . A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15:155–63 doi:10.1016/j.jcm.2016.02.012 pmid:27330520

   CrossRefPubMed
10. 10.↵
    1. Landis JR,
    2. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74 doi:10.2307/2529310

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Chew AP,
    2. Gupta G,
    3. Alatakis S, et al

    . Hippocampal calcification prevalence at CT: a retrospective review. Radiology 2012;265:504–10 doi:10.1148/radiol.12110636 pmid:22875797

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Kockelkoren R,
    2. De Vis JB,
    3. Stavenga M, et al

    ; DUST Study Group. Hippocampal calcification on brain CT: prevalence and risk factors in a cerebrovascular cohort. Eur Radiology 2018;28:3811–18 doi:10.1007/s00330-018-5372-8 pmid:29619516

    CrossRefPubMed
13. 13.↵
    1. de Brouwer EJM,
    2. Kockelkoren R,
    3. Claus JJ, et al

    . Hippocampal calcifications: risk factors and association with cognitive function. Radiology 2018;288:815–20 doi:10.1148/radiol.2018172588 pmid:29893650

    CrossRefPubMed
14. 14.↵
    1. Mathijssen G,
    2. van Valen E,
    3. de Jong PA, et al

    . The association between intracranial calcifications and symptoms in patients with primary familial brain calcification. J Clin Med 2024;13:828 doi:10.3390/jcm13030828

    CrossRefPubMed